XML 94 R80.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
3 Months Ended 12 Months Ended
Apr. 01, 2017
USD ($)
Dec. 31, 2016
USD ($)
Oct. 01, 2016
USD ($)
Jul. 02, 2016
USD ($)
Apr. 02, 2016
USD ($)
Dec. 26, 2015
USD ($)
Sep. 26, 2015
USD ($)
Jun. 27, 2015
USD ($)
Apr. 01, 2017
USD ($)
unit
Apr. 02, 2016
USD ($)
Mar. 28, 2015
USD ($)
Segment Reporting Information [Line Items]                      
Number of business units | unit                 4    
Net revenues before foreign exchange impact                 $ 899,580,000 $ 910,515,000 $ 883,832,000
Effect of exchange rates                 (13,464,000) (1,683,000) 26,541,000
Net revenues $ 228,066,000 $ 227,841,000 $ 220,253,000 $ 209,956,000 $ 242,342,000 $ 233,384,000 $ 219,693,000 $ 213,413,000 886,116,000 908,832,000 910,373,000
Segment operating income                 296,560,000 315,230,000 317,507,000
Corporate operating expenses                 176,372,000 199,072,000 193,910,000
Effect of exchange rates                 (4,772,000) 3,546,000 13,906,000
Restructuring and turnaround costs                 34,337,000 42,185,000 69,697,000
Deal amortization                 27,107,000 28,958,000 30,184,000
Impairment of assets                 73,353,000 97,230,000 0
Contingent consideration income                 0 (4,727,000) (2,918,000)
Operating (loss) income (57,506,000) $ 21,212,000 $ 24,794,000 $ (7,881,000) (5,550,000) $ (61,177,000) $ 19,179,000 $ 3,606,000 (19,381,000) (43,942,000) 40,540,000
Depreciation and amortization                 89,733,000 89,911,000 86,053,000
Long-lived assets 323,862,000       337,634,000       323,862,000 337,634,000 321,948,000
Plasma [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 410,727,000 381,776,000 352,911,000
Blood center disposables                      
Segment Reporting Information [Line Items]                      
Net revenues                 303,890,000 355,108,000 386,147,000
Cell Processing [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 105,376,000 112,483,000 120,434,000
Hemostasis Management [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 66,123,000 59,465,000 50,881,000
United States                      
Segment Reporting Information [Line Items]                      
Net revenues                 522,686,000 519,440,000 494,788,000
Long-lived assets 241,610,000       231,744,000       241,610,000 231,744,000 208,439,000
Japan                      
Segment Reporting Information [Line Items]                      
Net revenues                 79,266,000 81,411,000 88,298,000
Long-lived assets 1,691,000       2,022,000       1,691,000 2,022,000 1,618,000
Europe                      
Segment Reporting Information [Line Items]                      
Net revenues                 166,007,000 187,725,000 215,575,000
Long-lived assets 12,952,000       18,672,000       12,952,000 18,672,000 27,786,000
Asia                      
Segment Reporting Information [Line Items]                      
Net revenues                 109,858,000 111,758,000 102,095,000
Long-lived assets 34,174,000       40,235,000       34,174,000 40,235,000 39,032,000
Other                      
Segment Reporting Information [Line Items]                      
Net revenues                 8,299,000 8,498,000 9,617,000
Long-lived assets 33,435,000       44,961,000       33,435,000 44,961,000 45,073,000
Japan                      
Segment Reporting Information [Line Items]                      
Net revenues before foreign exchange impact                 74,695,000 84,270,000 83,547,000
Segment operating income                 32,906,000 38,280,000 36,843,000
Depreciation and amortization                 827,000 774,000 767,000
Long-lived assets 21,412,000       33,159,000       21,412,000 33,159,000 31,810,000
EMEA [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues before foreign exchange impact                 198,396,000 204,192,000 219,153,000
Segment operating income                 49,105,000 47,168,000 60,101,000
Depreciation and amortization                 4,255,000 5,146,000 5,045,000
Long-lived assets 63,854,000       63,861,000       63,854,000 63,861,000 66,223,000
North America Plasma [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues before foreign exchange impact                 309,718,000 279,803,000 240,705,000
Segment operating income                 105,253,000 109,220,000 89,092,000
Depreciation and amortization                 13,022,000 12,944,000 11,229,000
Long-lived assets 142,164,000       116,001,000       142,164,000 116,001,000 101,272,000
All Other                      
Segment Reporting Information [Line Items]                      
Net revenues before foreign exchange impact                 316,771,000 342,249,000 340,427,000
Segment operating income                 109,296,000 120,562,000 131,471,000
Depreciation and amortization                 71,629,000 71,047,000 69,012,000
Long-lived assets $ 96,432,000       $ 124,613,000       $ 96,432,000 $ 124,613,000 $ 122,643,000